Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Radiofrequency Treatment vs Topical Therapy for Mild-to-Moderate Acne Vulgaris
NCT07805655Recruiting
- Sponsor
- Jeisys Medical
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in acne vulgaris (2 arms), sponsored by Jeisys Medical. Primary endpoint: Change From Baseline in Inflammatory Lesion Count at 12 weeks. Started Sep 2026; status: recruiting.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07805655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805655.